Avoid common mistakes on your manuscript.
1 Correction to: Pediatr Drugs https://doi.org/10.1007/s40272-017-0270-0
The article “Development of Guanfacine Extended-Release Dosing Strategies in Children and Adolescents with ADHD Using a Physiologically Based Pharmacokinetic Model to Predict Drug–Drug Interactions with Moderate CYP3A4 Inhibitors or Inducers”, written by Aiqun Li, Karen Yeo, Devin Welty, Haojing Rong, was originally published electronically on the publisher’s internet portal (currently SpringerLink) on 02nd November, 2017 without open access.
With the authors’ decision to opt for Open Choice the copyright of the article changed on 23rd November, 2017 to © The Authors 2017 and the article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, a link is provided to the Creative Commons license and any changes made are indicated.
The original article has been updated.
Author information
Authors and Affiliations
Corresponding author
Additional information
The original article can be found online at https://doi.org/10.1007/s40272-017-0270-0.
Rights and permissions
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Li, A., Yeo, K., Welty, D. et al. Correction to: Development of Guanfacine Extended-Release Dosing Strategies in Children and Adolescents with ADHD Using a Physiologically Based Pharmacokinetic Model to Predict Drug–Drug Interactions with Moderate CYP3A4 Inhibitors or Inducers. Pediatr Drugs 20, 205 (2018). https://doi.org/10.1007/s40272-017-0275-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40272-017-0275-8